Below are the financial statements of Piramal Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of INR | 2025 | 2024 |
|---|---|---|
| Revenue from operations | 91.51a | 81.71a |
| Other income (net) | 1.35a | 1.75a |
| Total income | 92.86a | 83.47a |
| Expenses | — | — |
| Cost of materials consumed | -20.56a | -19.77a |
| Purchases of stock-in-trade | -14.17a | -11.76a |
| Changes in inventories of finished goods, work-in-progress and stock-in-trade | -2.41a | -1.99a |
| Employee benefits expense | -23.07a | -20.3a |
| Finance costs | -4.22a | -4.48a |
| Depreciation, amortization and impairment expense | -8.16a | -7.41a |
| Other expenses (net) | -21.67a | -19.91a |
| Total expenses | -89.44a | -81.64a |
| Profit before share of net profit of associates, exceptional items and tax | 3.42a | 1.83a |
| Share of net profit of associates | 0.73a | 0.59a |
| Profit after share of net profit of associates before exceptional items and tax | 4.15a | 2.42a |
| Exceptional items | 0a | -0.63a |
| Profit after share of net profit of associates and before tax | 4.15a | 1.79a |
| Income tax expense | — | — |
| Current tax (including prior year taxes) | -3.1a | -1.85a |
| Deferred tax, net | -0.13a | -0.24a |
| Profit after tax for the year | 0.91a | 0.18a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Piramal Pharma’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.